Cargando…

Interdisciplinary Treatment of Malignant Chest Wall Tumors

Background: Chest wall resections for malignant chest wall tumors (MCWTs), particularly those with full-thickness chest wall involvement requiring reconstruction, present a therapeutic challenge for thoracic and plastic reconstructive surgeons. The purpose of this study was to review our experience...

Descripción completa

Detalles Bibliográficos
Autores principales: Khamitov, Koblandy, Dudek, Wojciech, Arkudas, Andreas, Haj Khalaf, Mohamed, Parjiea, Chirag, Higaze, Mostafa, Horch, Raymund E., Sirbu, Horia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532685/
https://www.ncbi.nlm.nih.gov/pubmed/37763172
http://dx.doi.org/10.3390/jpm13091405
_version_ 1785112019043614720
author Khamitov, Koblandy
Dudek, Wojciech
Arkudas, Andreas
Haj Khalaf, Mohamed
Parjiea, Chirag
Higaze, Mostafa
Horch, Raymund E.
Sirbu, Horia
author_facet Khamitov, Koblandy
Dudek, Wojciech
Arkudas, Andreas
Haj Khalaf, Mohamed
Parjiea, Chirag
Higaze, Mostafa
Horch, Raymund E.
Sirbu, Horia
author_sort Khamitov, Koblandy
collection PubMed
description Background: Chest wall resections for malignant chest wall tumors (MCWTs), particularly those with full-thickness chest wall involvement requiring reconstruction, present a therapeutic challenge for thoracic and plastic reconstructive surgeons. The purpose of this study was to review our experience with chest wall resection for primary and metastatic MCWTs, with a focus on perioperative outcomes and postoperative overall survival (OS). Methods: All patients who underwent surgical resection for primary and secondary MCWTs at our single institution between 2000 and 2019 were retrospectively analyzed. Results: A total of 42 patients (25 male, median age 60 years) operated upon with curative (n = 37, 88.1%) or palliative (n = 5, 11.9%) intent were reviewed. Some 33 (78%) MCWTs were of secondary origin. Chest wall reconstruction was required in 40 (95%) cases. A total of 13 (31%) patients had postoperative complications and one (2.3%) died perioperatively. The 5-year postoperative overall survival rate was 51.9%. The postoperative 5-year survival rate of 42.6% in patients with secondary MCWTs was significantly lower compared to the figure of 87.5% in patients with primary MCWTs. Conclusions: In well-selected patients, chest wall resections for primary and secondary MCWTs are feasible and associated with good perioperative outcomes. For secondary MCWTs, surgery can also be performed with palliative intent.
format Online
Article
Text
id pubmed-10532685
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105326852023-09-28 Interdisciplinary Treatment of Malignant Chest Wall Tumors Khamitov, Koblandy Dudek, Wojciech Arkudas, Andreas Haj Khalaf, Mohamed Parjiea, Chirag Higaze, Mostafa Horch, Raymund E. Sirbu, Horia J Pers Med Article Background: Chest wall resections for malignant chest wall tumors (MCWTs), particularly those with full-thickness chest wall involvement requiring reconstruction, present a therapeutic challenge for thoracic and plastic reconstructive surgeons. The purpose of this study was to review our experience with chest wall resection for primary and metastatic MCWTs, with a focus on perioperative outcomes and postoperative overall survival (OS). Methods: All patients who underwent surgical resection for primary and secondary MCWTs at our single institution between 2000 and 2019 were retrospectively analyzed. Results: A total of 42 patients (25 male, median age 60 years) operated upon with curative (n = 37, 88.1%) or palliative (n = 5, 11.9%) intent were reviewed. Some 33 (78%) MCWTs were of secondary origin. Chest wall reconstruction was required in 40 (95%) cases. A total of 13 (31%) patients had postoperative complications and one (2.3%) died perioperatively. The 5-year postoperative overall survival rate was 51.9%. The postoperative 5-year survival rate of 42.6% in patients with secondary MCWTs was significantly lower compared to the figure of 87.5% in patients with primary MCWTs. Conclusions: In well-selected patients, chest wall resections for primary and secondary MCWTs are feasible and associated with good perioperative outcomes. For secondary MCWTs, surgery can also be performed with palliative intent. MDPI 2023-09-20 /pmc/articles/PMC10532685/ /pubmed/37763172 http://dx.doi.org/10.3390/jpm13091405 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Khamitov, Koblandy
Dudek, Wojciech
Arkudas, Andreas
Haj Khalaf, Mohamed
Parjiea, Chirag
Higaze, Mostafa
Horch, Raymund E.
Sirbu, Horia
Interdisciplinary Treatment of Malignant Chest Wall Tumors
title Interdisciplinary Treatment of Malignant Chest Wall Tumors
title_full Interdisciplinary Treatment of Malignant Chest Wall Tumors
title_fullStr Interdisciplinary Treatment of Malignant Chest Wall Tumors
title_full_unstemmed Interdisciplinary Treatment of Malignant Chest Wall Tumors
title_short Interdisciplinary Treatment of Malignant Chest Wall Tumors
title_sort interdisciplinary treatment of malignant chest wall tumors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532685/
https://www.ncbi.nlm.nih.gov/pubmed/37763172
http://dx.doi.org/10.3390/jpm13091405
work_keys_str_mv AT khamitovkoblandy interdisciplinarytreatmentofmalignantchestwalltumors
AT dudekwojciech interdisciplinarytreatmentofmalignantchestwalltumors
AT arkudasandreas interdisciplinarytreatmentofmalignantchestwalltumors
AT hajkhalafmohamed interdisciplinarytreatmentofmalignantchestwalltumors
AT parjieachirag interdisciplinarytreatmentofmalignantchestwalltumors
AT higazemostafa interdisciplinarytreatmentofmalignantchestwalltumors
AT horchraymunde interdisciplinarytreatmentofmalignantchestwalltumors
AT sirbuhoria interdisciplinarytreatmentofmalignantchestwalltumors